Clinical trials
Phase 1 Hemoglobinuria, Paroxysmal trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wuhan Createrna Science and Technology Co., Ltd | 4 |
| Apellis Pharmaceuticals, Inc. | 2 |
| Haisco Pharmaceutical Group Co., Ltd. | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Amyndas Pharmaceuticals S.A. | 1 |
| BioCryst Pharmaceuticals | 1 |
| Bisirna Therapeutics Pte. Ltd. | 1 |
| Chengdu Suncadia Medicine Co., Ltd. | 1 |
| Kira Pharmacenticals (US), LLC. | 1 |
| Longbio Pharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemoglobinuria, Paroxysmal | 21 |
| Anemia | 2 |
| Hematologic Diseases | 2 |
| Hemoglobinuria | 2 |
| Hemolysis | 2 |
| Anemia, Refractory | 1 |
| Blast Crisis | 1 |
| Congenital Abnormalities | 1 |
| Glomerulonephritis, IGA | 1 |
| Leukemia, Myeloid, Accelerated Phase | 1 |
Trials
Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.